Global Molecular Biology Enzymes, Kits, and Reagents Market - Segmented by Product (Kits and Enzymes), by Application, by End-User and Geography - Growth, Trends, and Forecast (2022 - 2030)

Molecular Biology Enzymes, Kits, and Reagents Market Overview

The Molecular Biology Enzymes, Kits, and Reagents Market is expected to register a growth rate of 15.4%, over the forecast period. Molecular biology enzymes are natural proteins produced by living organisms (animals, plants, and bacteria) and are highly selective biochemical catalysts. Molecular biology reagents are chemicals used in molecular biology reactions to optimize the workflow. Molecular Biology Enzymes, Kits, and Reagents are used for the analysis of cell surface markers that act as diagnostic and/or therapeutic targets.

Increased Research Activities and R&D Investments in the Life Science Industry Boosting the Growth of Molecular Biology Enzymes, Kits, and Reagents Market

R&D is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind’s benefit in the future. The rate of growth in R&D funding in 2015 and the location where the growth is centered are both significant. However, the trends suggest a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors. As per the 2016 Global R&D funding forecast, this year sponsored by the Industrial Research Institute (IRI), Washington, D.C., revealed that global R&D investments is likely to increase by 3.5% in 2016 to a total of $1.948 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus increased research and R&D investments in the life science industry are augmenting the growth of the market.
In addition, a growing number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

High Costs and Limited Reimbursements for Genetic Testing Hindering the Growth of Molecular Biology Enzymes, Kits, and Reagents Market

Genetic tests are generally expensive and have always been a barrier in the growth of the genetic testing market. Several genetic tests help in identifying whether a woman carries one of several strains of the human papillomavirus (the strains that increase the risk of getting cervical cancer), these tests are less expensive. However, a few genetic tests, such as pre-implantation testing (pre-implantation genetic diagnosis (PGD)), fecal DNA testing, and others are usually expensive and are not covered by insurance providers. In Europe, the costs of data analysis and storage, interpreting the results, counseling services, and follow-up care has led to an increase in the overall health-care costs associated with genetic testing. Thus, the expensive nature of genetic tests negatively affects the market, which, in a few cases, are not reimbursed through insurance, thereby, affecting an individual in the form of an out-of-pocket payment. In addition to this, the import duty by the government on genetic tests kits acts as a barrier to the growth of the genetic testing market.

Asia-Pacific is Expected to Provide Large Growth Opportunities, Over the Forecast Period, in the Global Molecular Biology Enzymes, Kits, and Reagents Market

The molecular biology enzymes, kits, and reagents market in several Asia-Pacific countries, particularly, China, Japan, and India, are expected to witness high growth, over the forecast period. This can be attributed to the increasing government interest in biomedical and biotechnology industries, outsourcing of clinical research activities to China, the involvement of industry players in the Japanese market, growing pharmaceutical industry in India backed by government initiatives to drive market growth, and initiatives by non-profit organizations.

Key Developments in the Market

• May 2018: Illumina Acquired Edico Genome to accelerate genomic data analysis.
• Jan 2018: Illumina launched iSeq 100 sequencing system.

Major Players: AGILENT TECHNOLOGIES, F. HOFFMANN-LA ROCHE LTD, ILLUMINA INC., LUCIGEN CORPORATION, MERCK KGAA, NEW ENGLAND BIOLABS INC., PROMEGA CORPORATION, QIAGEN NV, TAKARA BIO INC., and THERMO FISHER SCIENTIFIC INC., among others.

Reasons to Purchase this Report

• Current and future of Molecular Biology Enzymes, Kits, and Reagents market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• Information on the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, over the forecast period
• Identification of the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please contact our representative, who will ensure that you to get a report that suits your needs

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports